Research News
View articles by month and year
-
Experts Release Report Detailing Environmental Breast Cancer Risks
An expert report says that combination HRT, being overweight after menopause, and drinking alcohol are definitely linked to higher breast cancer risk.
-
OncotypeDx Test Can Help Decide if Radiation Needed After DCIS Surgery
The OncotypeDx test can help doctors decide if women diagnosed with DCIS need radiation therapy.
-
Afinitor Helps Slow Growth of Certain Advanced-Stage Breast Cancers
New information from the BOLERO-2 study shows that women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage or metastatic breast cancer who got Afinitor and Aromasin in combination lived more than twice as long without the cancer growing than women who got only Aromasin.
-
Brachytherapy May Not Be as Effective as Whole-Breast Radiation in Reducing Recurrence Risk
Results from a large study suggest that brachytherapy may not be as effective as whole-breast radiation therapy at preventing breast cancer recurrence.
-
Research Finds Links Between Obesity, Diabetes, and Breast Cancer
A very large study has found links between higher breast cancer risk and diabetes and obesity.
-
Xgeva More Likely to Cause Osteonecrosis of the Jaw in Women Diagnosed with Advanced-Stage Breast Cancer
Research suggests that people diagnosed with advanced-stage breast or prostate cancer who get Xgeva are about twice as likely to develop osteonecrosis of the jaw compared to people with other advanced-stage cancers treated with Xgeva.
-
Fracture Risk in Younger Women Being Treated for Breast Cancer Higher Than Thought
A study found that about 16% of premenopausal women treated for early-stage breast cancer broke a bone during treatment or in the years after treatment; this rate was 60% higher than expected.
-
No Link Between Family History and Risk for Younger Women
For women age 40 to 49, a study found no link between family history and the risk of being diagnosed with breast cancer.
-
Canadian Task Force Changes Breast Cancer Screening Recommendations
A Canadian task force has recommended that routine screening mammograms should start at age 50 instead of age 40.
-
FDA Removes Breast Cancer Indication from Avastin
On Nov. 18, 2011 FDA Commissioner Margaret Hamburg decided to remove the breast cancer indication from Avastin.
